Reviews of sessions from HOPA Ahead 2019.
New advances in treatment options for Chronic Lymphocytic Leukemia (CLL) were examined in the presentation given by Alison Duffy, PharmD, of the Maryland University School of Pharmacy, at the 2019 Hematology/Oncology Pharmacy Association Annual Conference in Fort Worth, TX. Read more.
Sunitinib is effective in those categorized with favorable risk Renal Cell Carcinoma, according to a survey of the current research by Kinjal Parikh, PharmD, associate director of clinical strategy hematology/oncology for Medscape, at the 2019 Hematology/Oncology Pharmacy Association Annual Conference in Fort Worth, TX. Read more.
Brentuximab Vedotin (BV) is effective and safe in patients with advanced staged Hodgkin’s Lymphoma according to the presentation by Brianne Dixon, PharmD, a lymphoma clinical pharmacist for Memorial Sloan Kettering Cancer Center, at 2019 Hematology/Oncology Pharmacy Association Annual Conference in Fort Worth, TX. Read more.
Physicians are especially vulnerable to developing compassion fatigue, which can lead to burnout. As such, these physicians need to take steps ensure they preserve their own physical and mental health, according to a presentation by Justin Baker, MD, an oncologist with St Jude Children’s Research Hospital. Read more.
This message is being sent by HOPA on behalf of an external organization. HOPA does not endorse any information or recommendations contained herein nor does it verify the accuracy of the content of this third-party communication. The information presented in this message is not meant to serve as a guideline for patient management. Any procedures, medications, or other course of diagnosis or treatment discussed or suggested should not be used by clinicians without evaluation of their patients' conditions and consideration of possible contraindications. Please review any applicable manufacturer's product information.